GLG News Analyses of the following article:

Breast Cancer - Diagenic Announces Launch Of First Breast Cancer Gene-Expression Blood Test

view article

Published at: www.medicalnewstoday.com

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Breast Cancer Test from DiaGenic ASA

December 15, 2008

DiaGenic's new gene-based, molecular diagnostic BCtect assay for breast cancer could increase the number of women tested for this disease and reduce its growing mortality.  Breast cancer is the second leading cause of death in Indian women, with over 100,000 dying from this disease each year.  This non-invasive blood test could encourage more women to be tested, as opposed to tests that use actual breast tissue.

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Work for one of the world's leading organizations? Get started now.

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software